The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-12 of 12 articles
Preprocedural physiological assessment of coronary disease patterns to predict haemodynamic outcomes post-PCI
Kotoku N,
Ninomiya K,
Masuda S,
O’Leary N,
Garg S,
Naito M,
Miyashita K,
Tobe A,
Kageyama S,
Tsai TY,
Revaiah PC,
Tu S,
Kozuma K,
Kawashima H,
Ishibashi Y,
Nakazawa G,
Takahashi K,
Okamura T,
Miyazaki Y,
Tateishi H,
Nakamura M,
Kogame N,
Asano T,
Nakatani S,
Morino Y,
Ishida M,
Katagiri Y,
Ono M,
Hara H,
Sotomi Y,
Tanabe K,
Ozaki Y,
Muramatsu T,
Dijkstra J,
Onuma Y,
Serruys P
November 14, 2023 | 10.4244/EIJ-D-23-00516
Sirolimus-eluting stents with ultrathin struts versus everolimus-eluting stents for patients undergoing percutaneous coronary intervention: final three-year results of the TALENT trial
de Winter R,
Zaman A,
Hara H,
Gao C,
Ono M,
Garg S,
Smits PC,
Tonino P,
Hofma S,
Moreno R,
Choudhury A,
Petrov I,
Cequier A,
Colombo A,
Kaul U,
Onuma Y,
Serruys P
August 19, 2022 | 10.4244/EIJ-D-21-00766
Ticagrelor monotherapy versus aspirin monotherapy at 12 months after percutaneous coronary intervention: a landmark analysis of the GLOBAL LEADERS trial
Ono M,
Hara H,
Kawashima H,
Gao C,
Wang R,
Wykrzykowska JJ,
Piek J,
Garg S,
Hamm C,
Steg G,
Valgimigli M,
Windecker S,
Vranckx P,
Onuma Y,
Serruys P
August 5, 2022 | 10.4244/EIJ-D-21-00870
A comparison of risk prediction models for patients with acute coronary syndromes
March 18, 2022 | 10.4244/EIJ-D-21-00536
Reply: Composite endpoints in clinical trials - simplicity or perfection?
January 28, 2022 | 10.4244/EIJ-D-21-00440R
Statistical methods for composite endpoints
Hara H,
van Klaveren D,
Kogame N,
Chichareon P,
Modolo R,
Tomaniak M,
Ono M,
Kawashima H,
Takahashi K,
Capodanno D,
Onuma Y,
Serruys P
April 2, 2021 | 10.4244/EIJ-D-19-00953
Coronary interventions in 2020: the year in review
February 5, 2021 | 10.4244/EIJ-D-20-01343
A randomised controlled trial of the sirolimus-eluting biodegradable polymer ultra-thin Supraflex stent versus the everolimus-eluting biodegradable polymer SYNERGY stent for three-vessel coronary artery disease: rationale and design of the Multivessel TALENT trial
Hara H,
Gao C,
Kogame N,
Ono M,
Kawashima H,
Wang R,
Morel M,
O'Leary N,
Sharif F,
Möllmann H,
Reiber J,
Sabaté M,
Zaman A,
Wijns W,
Onuma Y,
Serruys P
December 18, 2020 | 10.4244/EIJ-D-20-00772
The year in review: coronary interventions
Gao C,
Wang R,
Sharif F,
Takahashi K,
Ono M,
Hara H,
Tomaniak M,
Kawashima H,
Modolo R,
van Geuns R,
Capodanno D,
Byrne RA,
Wijns W,
Onuma Y,
Serruys P
April 17, 2020 | 10.4244/EIJ-D-19-01124
Signet ring-like appearance: specific feature of vulnerable plaques detected by 320-slice multidetector computed tomography
February 20, 2014 | 10.4244/EIJV9I10A210
Latest news
NEW ISSUE
The Bifurcation ARC consensus; impact of P2Y12 de-escalation in HBR; 5-year outcomes of the TARGET trial and more...
December 4, 2023
STATE-OF-THE-ART
Free access collection all year long
December 4, 2023
AHEAD OF PRINT
Poor improvement of post-PCI iFR in LAD
FREE ARTICLE - Mitsuaki Matsumura et al
November 30, 2023
AHEAD OF PRINT
Robotic-assisted CABG: clinical outcomes
FREE ARTICLE - Aleksander Dokollari et al
November 23, 2023
AHEAD OF PRINT
Pathophysiological CAD patterns predict outcomes post-PCI
FREE ARTICLE - Nozomi Kotoku et al
November 14, 2023
PCR London Valves 2023
November 16, 2023
AHEAD OF PRINT
Extra-mitral valve cardiac involvement in MR
FREE ARTICLE - Antonio Popolo Rubbio et al
November 9, 2023